Interim analysis of an ongoing 156-week extension study supports long-term safety, tolerability and efficacy of atogepant 60 mg to prevent chronic and episodic migraine
Global Phase-3 study initiation expected in the second half of 2024
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The virtual event will be attended by representatives from state & district health administration, corporates, industries, civil society, and NGOs as the country reiterates its commitment towards TB elimination by 2025
The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
Nadda noted that TB treatment coverage in India has increased from 59% to 85%
Subscribe To Our Newsletter & Stay Updated
